University of Birmingham forms spinout to develop new therapeutic target for rheumatoid arthritis

University of Birmingham Enterprise announces the formation of a new spinout company, Viatem Ltd, to develop and exploit the therapeutic potential of PEPITEM (Peptide Inhibitor of Trans-Endothelial Migration).